AMZN
Amazon.com, Inc.
AMZN has the edge over BRSL overall, supported by stronger modeled upside and lower modeled downside.
BRSL
Brightstar Lottery
BRSL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BRSL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Weak | |
| Under pressure |
BRSL's profitability is currently strong, and its revenue is stable, but its cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BRSL in the historical PE scenario, which offers more potential upside but is not a forecast.
BRSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $9.54 | -1.5% |
| Current | 9.8x | $9.69 | — |
| Fair | 17x | $17.29 | +78% |
| Forward | 18x | $9.69 | — |
| Expensive | 24x | $23.94 | +147% |
Historical ranges are pointers, not guarantees.
BRSL's PE is in its cheap range at 9.8x. Analysts expect earnings to fall, which would put today's price at 18x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BRSL on the outlook, with more favorable earnings and revenue expectations.
BRSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect BRSL's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BRSL on earnings, with more consistent year-over-year improvement.
BRSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.54 | -46% |
| Q2 2026 | $0.99 | +4.2% |
| Q1 2026 | $0.52 | -64% |
| Q4 2025 | $0.45 | -74% |
| Q3 2025 | $1.20 | +97% |
| Q4 2022 | $1.35 | -42% |
| Q4 2021 | $2.33 | +$6.72 |
| Q4 2020 | -$4.39 | -$4.30 |
| Q4 2019 | -$0.09 | +$0.01 |
BRSL's earnings per share have fallen from their peak: $0.99 over the past year, against $2.33 in late 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BRSL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
BRSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $584M | -7.3% |
| Q1 2026 | $587M | +0.7% |
| Q4 2025 | $668M | +2.5% |
| Q3 2025 | $629M | +7.3% |
| Q2 2025 | $630M | +2.8% |
| Q1 2025 | $583M | -12% |
| Q4 2024 | $652M | -4.3% |
| Q4 2023 | $681M | -84% |
BRSL's revenue fell from its 2016 peak and has held roughly level since: $584M last quarter, down 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -4.5 points |
| Q1 2026 | 22% | -2 points |
| Q4 2025 | 35% | +7.4 points |
| Q3 2025 | 29% | +10 points |
| Q2 2025 | 25% | -4 points |
| Q1 2025 | 24% | -9.5 points |
| Q4 2024 | 28% | -3.2 points |
| Q3 2024 | 19% | -3.1 points |
BRSL has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BRSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.5B | -747% |
| Q1 2026 | $55M | -63% |
| Q4 2025 | -$270M | -203% |
| Q3 2025 | -$531.8M | -330% |
| Q2 2025 | $225.9M | -26% |
| Q1 2025 | $148M | +74% |
| Q4 2024 | $261M | -25% |
| Q4 2023 | $348.9M | -40% |
BRSL has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BRSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1M shares |
| 1 year | -8.4% | -17M shares |
| 3 years | -10% | -20.8M shares |
BRSL has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $15M |
| Q1 2026 | $30M |
| Q4 2025 | $16.9M |
| Q3 2025 | $262.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BRSL spent $324M buying back its own shares over the past year, after none the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BRSL on leverage, with a lower net debt burden relative to earnings.
BRSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 4.3x | High |
| Q3 2024 | 5.2x | High |
BRSL's net debt is about 3.4 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BRSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 20.7 | Neutral |
BRSL's weekly RSI is 36 (neutral) and its Stochastic is 21 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BRSL PE vs Consumer Cyclical Sector
| Metric | BRSL | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 18x | 46% below |
| PE % | 19 | 47 | 28 pts below |
BRSL has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BRSL on trend strength, trading above more of its moving averages.
BRSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.73 | 0.4% below |
| 20 week MA | $10.5 | 7.7% below |
| 50 week MA | $12.2 | 20% below |
| 100 week MA | $14.3 | 32% below |
| 200 week MA | $19.7 | 51% below |
BRSL is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BRSL on returns for 2026, with the stronger performance.
BRSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.0 | $16.3 | +9.1% |
| 2021 | $16.3 | $29.0 | +77% |
| 2022 | $29.0 | $22.5 | -22% |
| 2023 | $22.5 | $27.4 | +22% |
| 2024 | $27.4 | $17.1 | -38% |
| 2025 | $17.1 | $15.7 | -7.9% |
| 2026 YTD | $15.7 | $9.69 | -38% |
BRSL has finished lower in three of the last six years. It's down 38% so far in 2026.